RedPine, a Guangzhou-based medical device company, announced that it had raised over hundreds of millions yuan in a Series C financing. Eight Roads continued to double down in this round, following leading its Series A round in 2020 and participating in its Series B round in 2021. The proceeds will be mainly used for pipeline development, manufacturing capacity expansion, and commercialization both domestically and internationally.

Founded in 2015, RedPine is disposable endoscope MedTech platform, and the portfolio covers the endoscopes across various specialties, e.g. Urology, OB/GYN, Gastroenterology etc., and endoscopic consumables.

Dr. Lei Shi, Partner at Eight Roads, said: “RedPine has established its leadership in the disposable endoscope industry, given its strong track record and expertise in R&D, manufacture, and commercialization, etc. Eight Roads is honored to accompany Redpine along the way becoming a global platform."